You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
12 August 2019
Beiersdorf's Consumer business reported worldwide sales up by 5.3% on an organic basis in the first half of 2019. Chief executive officer Stefan De Loecker said the "needle is moving in the right direction" following the launch of a new strategy to boost the performance of the business.
9 August 2019
US-based specialty retailer Vitamin Shoppe is set to be acquired by Liberty Tax – the parent company of Liberty Tax Service and Buddy's Home Furnishings – in an all-cash transaction worth around USD208 million.
9 August 2019
Bidvest has taken control of Adcock Ingram, Teva is seeking a new chief financial officer and the South African industry association is changing its name.
7 August 2019
Walgreens Boots Alliance (WBA) plans to close around 200 more Walgreens stores following a review of its "real estate footprint in the US".
6 August 2019
Navamedic will launch Alflorex for IBS in Denmark, Iceland and Norway as part of a strategic partnership with PrecisionBiotics, a subsidiary of the Irish probiotic specialist Alimentary Health Group.
5 August 2019
RB has announced a strategic investment and partnership deal with Your.MD, the digital technology company with a free service that uses artificial intelligence to provide "Trusted Health Information".
5 August 2019
Bayer has "no second thoughts" about the future of its Consumer Health division within the company, according to chief executive officer Werner Baumann.
5 August 2019
Bayer's Consumer Health division reported worldwide sales up by 2.1% on a currency- and portfolio-adjusted basis to EUR1.44 billion (USD1.61 billion). Werner Baumann, Bayer's chief executive officer, said the results demonstrated that Heiko Schipper and his team were "clearly making progress in turn...
5 August 2019
Sanofi's Consumer Healthcare business reported worldwide sales up by 1.1% at constant exchange rates in the second quarter of 2019. The company said brand divestments and tightening regulatory requirements, particularly in Europe, had reduced growth by around two percentage points.
5 August 2019
RB said it had "focused and detailed action plans in place" to accelerate growth at its Health division, as sales fell by 1% on a like-for-like basis in the second quarter of 2019.